drugset / Trial / NCT00953628
Endometrial Advancement After Rec or u-HCG Triggering
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to investigate any potential advantages of replacing human chorionic gonadotropin (uhCG) with recombinant human chorionic gonadotropin (recHCG) for final oocyte maturation with regard to Ovarian hyperstimulation syndrome (OHSS)pathophysiology, endometrium receptivity and embryo quality and clinical pregnancy.
Timeline
- Start
- 2005-08
- Primary completion
- 2006-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | human chorionic gonadotropin | Protein / enzyme biologic | 10000 iu | — |
| Subject | recombinant HCG | Protein / enzyme biologic | 250 ug | — |